Chemours Co. (CC)

39.29
0.47 1.18
NYSE
Prev Close 39.76
Open 39.83
Day Low/High 39.08 / 39.95
52 Wk Low/High 25.17 / 53.25
Volume 1.06M
Exchange NYSE
Shares Outstanding 166.28B
Market Cap 6.61B
Div & Yield N.A. (N.A)

Latest News

Chemours Finally Has the Right Mix

Chemours Finally Has the Right Mix

The long correction in the chemicals company is over and traders can now go long on strength.

Make Some Bucks with Buckeye?

Make Some Bucks with Buckeye?

Beaten down pipeline MLP offers an attractive reward vs. risk profile.

'Lock and Roll' on Chemours

'Lock and Roll' on Chemours

We'll roll our CC profits into a November call spread.

Chemours Has the Right Chemistry

Chemours Has the Right Chemistry

The stock has been having a good year, but it's breaking out higher today.

Sometimes You Crave 'Junk Food' -- Even When Investing

Sometimes You Crave 'Junk Food' -- Even When Investing

At Libbey, the glass may be half empty, but it's likely to fill up again.

Sometimes You Crave 'Junk Food'

Sometimes You Crave 'Junk Food'

At Libbey, the glass may be half empty, but it's likely to fill up again.

These Stocks Have Changed Direction

These Stocks Have Changed Direction

Finding bullish and bearish reversals in the market.

Cramer: Are You Paying Attention to These Boring Companies? You Should

Cramer: Are You Paying Attention to These Boring Companies? You Should

We ought to open our eyes to what we don't care about, to what's still made here.

Chemours upgraded at Jefferies

Chemours: My Chemical/Technical Romance

Chemours: My Chemical/Technical Romance

CC has made a strong upside move but more gains are anticipated in the weeks ahead.

'Higher Value' Chemistry Key to Turnaround Says Chemours CEO

'Higher Value' Chemistry Key to Turnaround Says Chemours CEO

Chemours is up over 153% year-to-date and more than 50% since a short-seller targeted the chemical maker.

Anything These Guys Are Selling, I'm not Buying

Anything These Guys Are Selling, I'm not Buying

When KKR and Apollo sell a stock it should be a huge red flag to investors to consider following suit.

Closing Bell: Chemours Spikes on Jury Verdict; U.S. Stocks Rally

Closing Bell: Chemours Spikes on Jury Verdict; U.S. Stocks Rally

Wall Street closed out the holiday-shortened week with a bang.

Cramer: Amazon Hits All-Time High Without Retail Folding

And that's distinctly good news for the overall market.

Here’s Short-Seller Andrew Left’s Latest Target

Here’s Short-Seller Andrew Left’s Latest Target

Shares of Chemours plunged on Friday on the heels of a bearish report written by short-seller Andrew Left of Citron Research.

Trending Tickers: SBUX , CC, BAC, ETFC, DNKN

U.S. markets falter Friday after an especially weak jobs report. 

Short-Seller Cites 'Evil' of DuPont Spinoff Chemours

Andrew Left says he feels 'guilty' bringing up the stock issue when the humanitarian issue is much bigger.

Chemours upgraded at Goldman

Chemours Sinks After Being Spun Off Into the Cold

The DuPont spinoff has a rapidly declining share price, hefty debt load and potentially high legal fees.

Cramer: Dow Chemical-DuPont Merger Will Instantly Create Value

The merged company can become multiple companies.

DuPont and PepsiCo: It's All About the Numbers

Differing results and dealings with Nelson Peltz produce a CEO winner and loser.

Buy DuPont Before Next Board Challenge

Buy DuPont Before Next Board Challenge

Peltz lost the last time, but next time may be different.

Always Be Greedy When Others Are Fearful

Always Be Greedy When Others Are Fearful

History shows this should be a good time to buy U.S. stocks.

Spin Is Positive for These New Independents

Spin Is Positive for These New Independents

With better economic conditions, California Resources and Chemours could more than double.

Chemours upgraded at JP Morgan

That Was the Week That Was

That Was the Week That Was

Let's review.

Weaving a Profit From Spinoffs

Weaving a Profit From Spinoffs

Picking up bargains post-spinoff can give outsized returns.